| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 12.35B | 12.78B | 12.39B | 11.46B | 12.64B | 12.04B |
| Gross Profit | 2.96B | 3.11B | 2.93B | 2.56B | 3.05B | 3.01B |
| EBITDA | 1.38B | 1.39B | 1.33B | 1.06B | 1.46B | 1.51B |
| Net Income | 670.00M | 270.00M | 676.00M | 527.00M | 767.00M | 870.00M |
Balance Sheet | ||||||
| Total Assets | 17.76B | 18.93B | 17.63B | 17.14B | 16.81B | 16.45B |
| Cash, Cash Equivalents and Short-Term Investments | 3.59B | 3.21B | 3.31B | 3.50B | 4.53B | 3.93B |
| Total Debt | 2.48B | 2.46B | 2.48B | 2.50B | 2.52B | 2.48B |
| Total Liabilities | 5.20B | 5.58B | 5.07B | 5.02B | 5.55B | 5.71B |
| Stockholders Equity | 12.56B | 13.34B | 12.56B | 12.11B | 11.25B | 10.74B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 130.00M | 95.00M | -830.00M | 951.00M | 1.60B |
| Operating Cash Flow | 0.00 | 984.00M | 1.02B | 289.00M | 1.17B | 1.91B |
| Investing Cash Flow | 0.00 | -851.00M | -942.00M | -1.07B | -238.00M | -252.00M |
| Financing Cash Flow | 0.00 | -263.00M | -261.00M | -302.00M | -341.00M | -246.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥23.13B | 8.13 | ― | 2.87% | 3.04% | 38.35% | |
73 Outperform | ¥8.81B | 9.18 | ― | 2.92% | 4.05% | 187.83% | |
65 Neutral | ¥17.53B | 5.19 | ― | 4.33% | 2.56% | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
56 Neutral | ¥10.47B | 39.24 | ― | 3.48% | 3.10% | -60.12% | |
54 Neutral | ¥11.06B | -4.86 | ― | ― | -3.09% | -68.39% | |
46 Neutral | ¥4.34B | -1.75 | ― | 1.06% | 8.16% | -1033.34% |